BSE
GRANULES

GRANULES INDIA LTD.-$

Drug Manufacturers-Specialty & Generic
Healthcare

Prices are adjusted according to historical splits.

GRANULES INDIA LTD.-$ Stock Price

Vitals

Today's Low:
₹306.05
Today's High:
₹318
Open Price:
₹316.4
52W Low:
₹266.5842
52W High:
₹379.4482
Prev. Close:
₹314
Volume:
179896

Company Statistics

Market Cap.:
₹71.04 billion
Book Value:
117.124
Revenue TTM:
₹44.78 billion
Operating Margin TTM:
14.67%
Gross Profit TTM:
₹22.18 billion
Profit Margin:
9.76%
Return on Assets TTM:
9.79%
Return on Equity TTM:
19.06%

Company Profile

GRANULES INDIA LTD.-$ had its IPO on under the ticker symbol GRANULES.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. GRANULES INDIA LTD.-$ has a staff strength of 3,650 employees.

Stock update

Shares of GRANULES INDIA LTD.-$ opened at ₹316.4 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹306.05 - ₹318, and closed at ₹307.7.

This is a -2.01% slip from the previous day's closing price.

A total volume of 179,896 shares were traded at the close of the day’s session.

In the last one week, shares of GRANULES INDIA LTD.-$ have increased by +0.75%.

GRANULES INDIA LTD.-$'s Key Ratios

GRANULES INDIA LTD.-$ has a market cap of ₹71.04 billion, indicating a price to book ratio of 3.2099 and a price to sales ratio of 2.009.

In the last 12-months GRANULES INDIA LTD.-$’s revenue was ₹44.78 billion with a gross profit of ₹22.18 billion and an EBITDA of ₹8.39 billion. The EBITDA ratio measures GRANULES INDIA LTD.-$'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, GRANULES INDIA LTD.-$’s operating margin was 14.67% while its return on assets stood at 9.79% with a return of equity of 19.06%.

In Q2, GRANULES INDIA LTD.-$’s quarterly earnings growth was a negative -61.4% while revenue growth was a negative 3.3%.

GRANULES INDIA LTD.-$’s PE and PEG Ratio

Forward PE
15.4083
Trailing PE
13.9762
PEG

Its diluted EPS in the last 12-months stands at ₹21 per share while it has a forward price to earnings multiple of 15.4083 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into GRANULES INDIA LTD.-$’s profitability.

GRANULES INDIA LTD.-$ stock is trading at a EV to sales ratio of 2.1282 and a EV to EBITDA ratio of 10.6939. Its price to sales ratio in the trailing 12-months stood at 2.009.

GRANULES INDIA LTD.-$ stock pays annual dividends of ₹0 per share, indicating a yield of 0.5% and a payout ratio of 11.63%.

Balance sheet and cash flow metrics

Total Assets
₹49.05 billion
Total Liabilities
₹18.14 billion
Operating Cash Flow
₹0
Capital Expenditure
₹0
Dividend Payout Ratio
11.63%

GRANULES INDIA LTD.-$ ended 2024 with ₹49.05 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹49.05 billion while shareholder equity stood at ₹28.35 billion.

GRANULES INDIA LTD.-$ ended 2024 with ₹0 in deferred long-term liabilities, ₹18.14 billion in other current liabilities, 242040000.00 in common stock, ₹28.11 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹2.92 billion and cash and short-term investments were ₹3.16 billion. The company’s total short-term debt was ₹8,108,820,000 while long-term debt stood at ₹1.49 billion.

GRANULES INDIA LTD.-$’s total current assets stands at ₹25.74 billion while long-term investments were ₹0 and short-term investments were ₹31.67 million. Its net receivables were ₹9.49 billion compared to accounts payable of ₹7.82 billion and inventory worth ₹11.49 billion.

In 2024, GRANULES INDIA LTD.-$'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, GRANULES INDIA LTD.-$ paid ₹0.12 in dividends in 2024.

Other key metrics

Current Trading Price
₹307.7
52-Week High
₹379.4482
52-Week Low
₹266.5842
Analyst Target Price

GRANULES INDIA LTD.-$ stock is currently trading at ₹307.7 per share. It touched a 52-week high of ₹379.4482 and a 52-week low of ₹379.4482. Analysts tracking the stock have a 12-month average target price of .

Its 50-day moving average was ₹306.69 and 200-day moving average was ₹301.52 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 4582.7% of the company’s stock are held by insiders while 2465.9% are held by institutions.

Frequently Asked Questions About GRANULES INDIA LTD.-$

The stock symbol (also called stock or share ticker) of GRANULES INDIA LTD.-$ is GRANULES

The IPO of GRANULES INDIA LTD.-$ took place on

Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)

Last Price
Chg
Chg%
Vimeo Inc (VMEO)
₹3.92
0
0%
₹30.65
-2.58
-7.76%
₹7.46
0
0%
₹0.97
0.02
+1.79%
₹4683.25
-262.95
-5.32%
₹7.73
-0.09
-1.15%
₹58.09
0.01
+0.02%
₹1.26
0.15
+13.51%
₹1.12
-0.08
-6.51%
₹0.2
0.01
+6.32%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
₹0.14
0.07
+100%
₹0.12
0.04
+45.29%
₹0.96
0.05
+5.4%
₹1.34
-0.35
-20.71%
Humbl Inc (HMBL)
₹0
0
0%

Top Gainers

Last Price
Chg
Chg%
₹0
0
+172200%
₹0
0
+51200%
₹283
280.03
+9428.62%
₹11.2
10.57
+1667.68%
Latch Inc (LTCHW)
₹0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
₹0.19
-123.15
-99.85%
₹0
-0.11
-99.55%
₹0
-0
-97.96%
₹0
-0.01
-93.94%
₹0.01
-0.06
-92.24%

About

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company’s APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

Address